| The role of ferroptosis in cancer development and treatment response B Lu, XB Chen, MD Ying, QJ He, J Cao, B Yang Frontiers in pharmacology 8, 992, 2018 | 368 | 2018 |
| Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway Q Wu, L Jiang, S Li, Q He, B Yang, J Cao Acta Pharmacologica Sinica 42 (1), 1-9, 2021 | 208 | 2021 |
| HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2 J Cao, L Sun, P Aramsangtienchai, NA Spiegelman, X Zhang, W Huang, ... Proceedings of the National Academy of Sciences 116 (12), 5487-5492, 2019 | 143 | 2019 |
| DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase JI Cao, X Chen, LI Jiang, B Lu, M Yuan, D Zhu, H Zhu, Q He, B Yang, ... Nature communications 11 (1), 1251, 2020 | 139 | 2020 |
| LncRNA-MM2P identified as a modulator of macrophage M2 polarization JI Cao, R Dong, L Jiang, Y Gong, M Yuan, J You, W Meng, Z Chen, ... Cancer immunology research 7 (2), 292-305, 2019 | 132 | 2019 |
| Tumor hypoxia enhances non-small cell lung cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling J Zhang, JI Cao, S Ma, R Dong, W Meng, M Ying, Q Weng, Z Chen, J Ma, ... Oncotarget 5 (20), 9664, 2014 | 132 | 2014 |
| All-trans retinoic acid prevents osteosarcoma metastasis by inhibiting M2 polarization of tumor-associated macrophages Q Zhou, M Xian, S Xiang, D Xiang, X Shao, J Wang, J Cao, X Yang, ... Cancer immunology research 5 (7), 547-559, 2017 | 123 | 2017 |
| DJ-1 as a human oncogene and potential therapeutic target J Cao, S Lou, M Ying, B Yang Biochemical pharmacology 93 (3), 241-250, 2015 | 121 | 2015 |
| Aldo–keto reductase AKR1C1–AKR1C4: Functions, regulation, and intervention for anti-cancer therapy CM Zeng, LL Chang, MD Ying, J Cao, QJ He, H Zhu, B Yang Frontiers in pharmacology 8, 119, 2017 | 117 | 2017 |
| USP10 promotes proliferation of hepatocellular carcinoma by deubiquitinating and stabilizing YAP/TAZ H Zhu, F Yan, T Yuan, M Qian, T Zhou, X Dai, J Cao, M Ying, X Dong, ... Cancer research 80 (11), 2204-2216, 2020 | 112 | 2020 |
| Inhibition of ubiquitin-specific proteases as a novel anticancer therapeutic strategy T Yuan, F Yan, M Ying, J Cao, Q He, H Zhu, B Yang Frontiers in pharmacology 9, 407019, 2018 | 106 | 2018 |
| SIRT7 is an RNA-activated protein lysine deacylase Z Tong, M Wang, Y Wang, DD Kim, JK Grenier, J Cao, S Sadhukhan, ... ACS chemical biology 12 (1), 300-310, 2017 | 101 | 2017 |
| Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells H Jing, X Zhou, X Dong, J Cao, H Zhu, J Lou, Y Hu, Q He, B Yang Cancer letters 294 (2), 167-177, 2010 | 96 | 2010 |
| Identification of PRDX6 as a regulator of ferroptosis B Lu, X Chen, Y Hong, H Zhu, Q He, B Yang, M Ying, J Cao Acta Pharmacologica Sinica 40 (10), 1334-1342, 2019 | 94 | 2019 |
| HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia XW Liu, Y Su, H Zhu, J Cao, WJ Ding, YC Zhao, QJ He, B Yang Pharmacological Research 62 (5), 416-425, 2010 | 92 | 2010 |
| The oxidation states of DJ-1 dictate the cell fate in response to oxidative stress triggered by 4-hpr: autophagy or apoptosis? J Cao, M Ying, N Xie, G Lin, R Dong, J Zhang, H Yan, X Yang, Q He, ... Antioxidants & redox signaling 21 (10), 1443-1459, 2014 | 89 | 2014 |
| An ICT-based fluorescent switch-on probe for hydrogen sulfide in living cells X Li, S Zhang, J Cao, N Xie, T Liu, B Yang, Q He, Y Hu Chemical communications 49 (77), 8656-8658, 2013 | 86 | 2013 |
| Celastrol acts as a potent antimetastatic agent targeting β1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase … H Zhu, XW Liu, TY Cai, J Cao, CX Tu, W Lu, QJ He, B Yang Journal of Pharmacology and Experimental Therapeutics 334 (2), 489-499, 2010 | 83 | 2010 |
| Ultra low power: Emerging devices and their benefits for integrated circuits AM Ionescu, L De Michielis, N Dagtekin, G Salvatore, J Cao, A Rusu, ... 2011 International Electron Devices Meeting, 16.1. 1-16.1. 4, 2011 | 81 | 2011 |
| Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2 M Ying, X Shao, H Jing, Y Liu, X Qi, J Cao, Y Chen, S Xiang, H Song, ... Blood, The Journal of the American Society of Hematology 131 (24), 2698-2711, 2018 | 79 | 2018 |
